News
Novo Nordisk A/S and Eli Lilly & Co, the pharmaceutical giants dominating the global obesity drug market, now face their ...
spot on news US on MSN1d
Lilly Becker won't drop her last name: 'I earned it'Lilly and Boris Becker have been officially divorced since September 2023. The 49-year-old still wants to keep her famous ...
The stock's fall snapped a four-day winning streak.
Though much of the dust has settled around Novo Nordisk and Eli Lilly’s crusade against compounded GLP-1s, the recent ...
Patients who took an experimental drug from Eli Lilly & Co. together with Novo Nordisk A/S’s Wegovy maintained muscle while ...
Artificial intelligence (AI) has the potential to transform several different areas of the healthcare industry.
Some doctors are concerned that patients taking weight loss drugs like Wegovy may be losing too much lean mass. A combination ...
Eli Lilly said on Thursday India's drug regulator had approved the launch of pre-filled injector pens of its blockbuster ...
New data from a Phase 3 trial show that the daily anti-obesity pill may be as safe and effective as drugs like Mounjaro and ...
After blueprinting an injectables facility in North Carolina in 2020, it didn’t take long for Eli Lilly to draw up designs ...
Eli Lilly faces market headwinds, slowing growth, and rising competition. Discover why now might be the time for LLY ...
Eli Lilly said on Thursday that India's drug regulator had approved the launch of pre-filled injector pens of its blockbuster weight-loss drug, Mounjaro, giving it more options to compete with Novo ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results